Alan Nicolle

Alan Nicolle’s background includes work across the fields of consultancy, global CROs, and big pharmaceutical companies before he joined MMS in 2014.

In his current position, Alan is responsible for the strategic leadership and planning of the operational side of the business. His main focus revolves around supporting and developing strategic initiatives, overseeing special projects that are of key importance, and assisting the COO with the creation of both short-term and long-term business goals. Alan collaborates closely with executive leadership and heads of all service lines to ensure alignment with the company’s key priorities. Additionally, he provides support to HR and finance functions when needed, aiming to maintain a successful business operational structure within various global regions.

Alan holds a Postgraduate Diploma in Information Technology and Society, as well as a Bachelor’s degree in Physiology and Biochemistry from the University of Southampton.

Suggested For You

webinar

December 4th, 2025

Writing with Quality Control in Mind: A Cross-functional Approach 

webinar

June 26th, 2025

De-Risking Development with Specialized Data Strategies: From Trial Design to Submission

perspectives

November 4th, 2025

4 Key Takeaways from the EMA - Health Canada Joint Review Process and Evaluation of Its Efficiency

perspectives

October 28th, 2025

New Updates on Clinical Trial Transparency and Regulatory Requirements: A Comprehensive Overview 

webinar

October 21st, 2025

A Practical Guide to Expedited Regulatory Pathways

perspectives

October 21st, 2025

Shaping Clinical Development Through Writing: Francesca’s Journey at MMS 

news

October 16th, 2025

MMS Named Finalist in the Fierce Life Sciences Innovation Awards for KerusCloud® Clinical Trial Simulation Platform 

perspectives

October 14th, 2025

CRO Partnerships and Biotech Agility: How Smaller Sponsors Gain Speed in Clinical Development  

perspectives

October 7th, 2025

From Academia to Building Medical Writing Partnerships: Jessica Murdock’s MMS Story  

news

October 2nd, 2025

MMS Announces Its Role in Supporting Gates Ventures and the GNPC to Deliver One of the World's Largest Proteomic Datasets for Neurodegenerative Diseases

perspectives

September 30th, 2025

Ready by Design: Endpoints, Feasibility, and Scenario Testing

news

September 24th, 2025

MMS Named Finalist in Citeline’s 2025 Scrip Awards for Best Contract Research Organization (CRO) – Specialist Providers